CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 24 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$29,000
-9.4%
21,443
+84.7%
0.00%
Q4 2021$32,000
-36.0%
11,6090.0%0.00%
Q3 2021$50,00011,6090.00%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,817,454$3,653,0000.07%
CSS LLC/IL 41,300$83,0000.00%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 35,000$70,0000.00%
CSS LLC/IL 33,900$68,0000.00%
Private Advisor Group, LLC 34,150$69,0000.00%
OPPENHEIMER & CO INC 38,500$77,0000.00%
High Net Worth Advisory Group LLC 1,000$2,0000.00%
VANGUARD GROUP INC 590,852$1,187,0000.00%
UBS Group AG 6,840$14,0000.00%
OSAIC HOLDINGS, INC. 8,321$25,0000.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders